Affymetrix (Nasdaq: AFFX) reported earnings on Jan. 31. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Affymetrix met expectations on revenues and exceeded expectations on earnings per share.

Compared to the prior-year quarter, revenue grew significantly and GAAP loss per share dropped.

Gross margins grew, operating margins dropped, net margins expanded.

Revenue details
Affymetrix chalked up revenue of $84.3 million. The 12 analysts polled by S&P Capital IQ predicted sales of $84.1 million on the same basis. GAAP reported sales were 30% higher than the prior-year quarter's $65.1 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at -$0.02. The 13 earnings estimates compiled by S&P Capital IQ averaged -$0.03 per share. GAAP EPS were -$0.17 for Q4 compared to -$0.21 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 53.6%, 30 basis points better than the prior-year quarter. Operating margin was -8.8%, 70 basis points worse than the prior-year quarter. Net margin was -14.5%, 810 basis points better than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $83.9 million. On the bottom line, the average EPS estimate is $0.01.

Next year's average estimate for revenue is $333.3 million. The average EPS estimate is $0.04.

Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 346 members out of 409 rating the stock outperform, and 63 members rating it underperform. Among 114 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 99 give Affymetrix a green thumbs-up, and 15 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Affymetrix is hold, with an average price target of $4.74.

Looking for alternatives to Affymetrix? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.